News
ESMO: Evidence builds for BioNTech's amplified CAR-T therapy
BioNTech has been thrust into the limelight with its mRNA-based vaccines and therapeutics – most notably its Pfizer-partnered COVID-19 shot – but the other side of its business is CAR-T the
